Short report: The sensitivity of Schistosoma japonicum to praziquantel: A field evaluation in areas with low endemicity of China

American Journal of Tropical Medicine and Hygiene

Volumn 86, Issue 5, 2012, Pages 834-836

  Wang, Wei ^a,b   Dai, Jian Rong ^a,b   Li, Hong Jun ^a,b   Shen, Xue Hui ^c   Liang, You Sheng ^a,b  

^a JIANGSU INSTITUTE OF PARASITIC DISEASES   (China)

^b Key Laboratory on Technology for Parasitic Diseases Prevention and Control   (China)

^c Dantu District Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL; ANTISCHISTOSOMAL AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHINA; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; ENDEMIC DISEASE; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS; SCHOOL CHILD; SINGLE DRUG DOSE; ANIMAL; DRUG EFFECT; DRUG SCREENING; FECES; METHODOLOGY; MIDDLE AGED; PARASITOLOGY; PATHOGENICITY; PREVALENCE; SCHISTOSOMIASIS JAPONICA;

SCHISTOSOMA JAPONICUM;

ADOLESCENT; ADULT; ANIMALS; CHILD; CHINA; DRUG EVALUATION; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; PRAZIQUANTEL; PREVALENCE; SCHISTOSOMA JAPONICUM; SCHISTOSOMIASIS JAPONICA; SCHISTOSOMICIDES; YOUNG ADULT;

EID: 84861813506     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2012.11-0701     Document Type: Article

References (29)

1. Engels D, Chitsulo L, Montresor A, Savioli L, 2002. The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Trop 82: 139-146.
2. Wang LD, Utzinger J, Zhou XN, 2008. Schistosomiasis control: experiences and lessons from China. Lancet 372: 1793-1795.
3. Zhou XN, Wang LY, Chen MG, Wu XH, Jiang QW, Chen XY, Zheng J, Utzinger J, 2005. The public health significance and control of schistosomiasis in China-then and now. Acta Trop 96: 97-105.
4. Zhou XN, Guo JG, Wu XH, Jiang QW, Zheng J, Dang H, Wang XH, Xu J, Zhu HQ, Wu GL, Li YS, Xu XJ, Chen HG, Wang TP, Zhu YC, Qiu DC, Dong XQ, Zhao GM, Zhang SJ, Zhao NQ, Xia G, Wang LY, Zhang SQ, Lin DD, Chen MG, Hao Y, 2007. Epidemiology of schistosomiasis in the People's Republic of China, 2004. Emerg Infect Dis 13: 1470-1476.
5. World Health Organization, 2002. Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. WHO Technical Report Series 912. Geneva: WHO.
6. Xiao SH, Keiser J, Chen MG, Tanner M, Utzinger J, 2010. Research and development of antischistosomal drugs in the People's Republic of China: a 60-year review. Adv Parasitol 73: 231-295.
7. Chen MG, 2005. Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience. Acta Trop 96: 168-176.
8. Fallon PG, Doenhoff MJ, 1994. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific. Am J Trop Med Hyg 51: 83-88.
9. Liang YS, Li HJ, Dai JR, Wang W, Qu GL, Tao YH, Xing YT, Li YZ, Qian K, Wei JY, 2011. Resistance of Schistosoma japonicum to praziquantel is experimentally induced in laboratory. Chin J Schisto Control 23: 605-610.
10. Ismail M, Metwally A, Farghaly A, Bruce J, Tao LF, Bennett JL, 1996. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am J Trop Med Hyg 55: 214-218.
11. Ismail M, Botros S, Metwally A, William S, Farghally A, Tao LF, Day TA, Bennett JL, 1999. Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am J Trop Med Hyg 60: 932-935.
12. Fallon PG, Sturrock RF, Niang AC, Doenhoff MJ, 1995. Diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. Am J Trop Med Hyg 53: 61-62.
13. Melman SD, Steinauer ML, Cunningham C, Kubatko LS, Mwangi IN, Wynn NB, Mutuku MW, Karanja DM, Colley DG, Black CL, Secor WE, Mkoji GM, Loker ES, 2009. Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl Trop Dis 3: e504.
14. Herwaldt BL, Tao LF, van Pelt W, Tsang VC, Bruce JI, 1995. Persistence of Schistosoma haematobium infection despite multiple courses of therapy with praziquantel. Clin Infect Dis 20: 309-315.
15. Alonso D, Muñoz J, Gascón J, Valls ME, Corachan M, 2006. Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection. Am J Trop Med Hyg 74: 342-344.
16. Yu DB, Li Y, Sleigh AC, Yu XL, Li YS, Wei WY, Liang YS, McManus DP, 2001. Efficacy of praziquantel against Schistosoma japonicum: field evaluation in an area with repeated chemotherapy compared with a newly identified endemic focus in Hunan, China. Trans R Soc Trop Med Hyg 95: 537-541.
17. Liang YS, Dai JR, Ning A, Yu DB, Xu XJ, Zhu YC, Coles GC, 2001. Susceptibility of Schistosoma japonicum to praziquantel in China. Trop Med Int Health 6: 707-714.
18. Wang W, Dai JR, Li HJ, Shen XH, Liang YS, 2010. Is there reduced susceptibility to praziquantel in Schistosoma japonicum? Evidence from China. Parasitology 137: 1905-1912.
19. Balen J, Zhao ZY, Williams GM, McManus DP, Raso G, Utzinger J, Zhou J, Li YS, 2007. Prevalence, intensity and associated morbidity of Schistosoma japonicum infection in the Dongting Lake region, China. Bull World Health Organ 85: 519-526.
20. Hong QB, Yang K, Huang YX, Sun LP, Yang GJ, Gao Y, Gao Y, Zhang LH, Zhou M, Steinmann P, Liang YS, 2011. Effectiveness of a comprehensive schistosomiasis japonica control program in Jiangsu province, China, from 2005 to 2008. Acta Trop 120S: S151-S157.
21. Chen XY, Wang LY, Cai JM, Zhou XN, Zheng J, Guo JG, Wu XH, Engels D, Chen MG, 2005. Schistosomiasis control in China: the impact of a 10-year World Bank Loan Project (1992-2001). Bull World Health Organ 83: 43-48.
22. Yu S, 1981. Studies on the methodology of egg collection with nylon bag for the diagnosis of Schistosoma japonicum infections. Chin J Med Lab Technol 4: 210-213.
23. Gönnert R, Andrews P, 1977. Praziquantel, a new broad-spectrum antischistosomal agent. Z Parasitenkd 52: 129-150.
24. Jordan P, Webbe G, Sturrock RF, 1993. Human Schistosomiasis. UK: CAB International.
25. Wu GL, 2002. A historical perspective on the immunodiagnosis of schistosomiasis in China. Acta Trop 82: 193-198.
26. Zhu YC, 2005. Immunodiagnosis and its role in schistosomiasis control in China: a review. Acta Trop 96: 130-136.
27. Katz N, Chaves A, Pellegrino J, 1972. A simple device for quantitative stool thick-smear techniques in schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 14: 397-400.
28. Lin DD, Liu JX, Liu YM, Hu F, Zhang YY, Xu JM, Li JY, Ji MJ, Bergquist R, Wu GL, Wu HW, 2008. Routine Kato-Katz technique underestimates the prevalence of Schistosoma japonicum: a case study in an endemic area of the People's Republic of China. Parasitol Int 57: 281-286.
29. Yu JM, de Vlas SJ, Jiang QW, Gryseels B, 2007. Comparison of the Kato-Katz technique, hatching test and indirect hemag-glutination assay (IHA) for the diagnosis of Schistosoma japonicum infection in China. Parasitol Int 56: 45-49.